nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—Naftifine—Tamoxifen—pancreatic cancer	0.407	1	CrCrCtD
Cinacalcet—CYP1A2—Dacarbazine—pancreatic cancer	0.0554	0.159	CbGbCtD
Cinacalcet—CYP1A2—Tamoxifen—pancreatic cancer	0.0441	0.127	CbGbCtD
Cinacalcet—CYP1A2—Erlotinib—pancreatic cancer	0.0375	0.108	CbGbCtD
Cinacalcet—CYP2D6—Tamoxifen—pancreatic cancer	0.0363	0.104	CbGbCtD
Cinacalcet—CYP1A2—Fluorouracil—pancreatic cancer	0.0325	0.0934	CbGbCtD
Cinacalcet—CYP2D6—Erlotinib—pancreatic cancer	0.0309	0.0888	CbGbCtD
Cinacalcet—CYP3A4—Tamoxifen—pancreatic cancer	0.0231	0.0664	CbGbCtD
Cinacalcet—CYP3A4—Erlotinib—pancreatic cancer	0.0196	0.0564	CbGbCtD
Cinacalcet—CYP3A4—Irinotecan—pancreatic cancer	0.0177	0.051	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—pancreatic cancer	0.0152	0.0438	CbGbCtD
Cinacalcet—CYP3A4—Docetaxel—pancreatic cancer	0.013	0.0373	CbGbCtD
Cinacalcet—CYP3A4—Sunitinib—pancreatic cancer	0.0129	0.0372	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—pancreatic cancer	0.00969	0.0278	CbGbCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—pancreatic cancer	0.00134	0.0166	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—CCKAR—pancreatic cancer	0.0013	0.0161	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatic cancer	0.00121	0.015	CbGpPWpGaD
Cinacalcet—CASR—E-cadherin signaling in keratinocytes—AKT1—pancreatic cancer	0.00119	0.0148	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatic cancer	0.00116	0.0144	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PRLHR—pancreatic cancer	0.00116	0.0143	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CNR2—pancreatic cancer	0.0011	0.0136	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SSTR3—pancreatic cancer	0.000987	0.0122	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SSTR1—pancreatic cancer	0.000947	0.0117	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PPY—pancreatic cancer	0.000928	0.0115	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—GCG—pancreatic cancer	0.000917	0.0113	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SSTR2—pancreatic cancer	0.000911	0.0113	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCKBR—pancreatic cancer	0.00088	0.0109	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.000874	0.0108	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—SST—pancreatic cancer	0.000857	0.0106	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00082	0.0101	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CNR1—pancreatic cancer	0.000791	0.00977	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.000782	0.00966	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SCT—pancreatic cancer	0.000717	0.00886	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCK—pancreatic cancer	0.000684	0.00845	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CNR2—pancreatic cancer	0.000667	0.00824	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—GLP1R—pancreatic cancer	0.000667	0.00824	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCKAR—pancreatic cancer	0.000656	0.00811	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SHH—pancreatic cancer	0.000598	0.00739	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PRLHR—pancreatic cancer	0.000596	0.00736	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—IAPP—pancreatic cancer	0.000591	0.0073	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTHLH—pancreatic cancer	0.000567	0.00701	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTCH1—pancreatic cancer	0.000567	0.00701	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000558	0.00689	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GDI1—pancreatic cancer	0.000546	0.00675	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GDI2—pancreatic cancer	0.000546	0.00675	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000535	0.00661	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PPY—pancreatic cancer	0.000525	0.00648	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SST—pancreatic cancer	0.000519	0.00641	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000515	0.00636	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—SSTR3—pancreatic cancer	0.000507	0.00626	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000497	0.00614	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—SSTR1—pancreatic cancer	0.000486	0.006	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CNR1—pancreatic cancer	0.000479	0.00591	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PPY—pancreatic cancer	0.000476	0.00589	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—SSTR2—pancreatic cancer	0.000468	0.00578	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—GCG—pancreatic cancer	0.000462	0.00571	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CCKBR—pancreatic cancer	0.000452	0.00558	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—AGTR1—pancreatic cancer	0.000441	0.00545	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—GAST—pancreatic cancer	0.000428	0.00528	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—SCT—pancreatic cancer	0.000405	0.00501	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—GAST—pancreatic cancer	0.000388	0.0048	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCK—pancreatic cancer	0.000387	0.00478	CbGpPWpGaD
Cinacalcet—Abdominal pain—Tamoxifen—pancreatic cancer	0.000382	0.00233	CcSEcCtD
Cinacalcet—Abdominal pain—Erlotinib—pancreatic cancer	0.000378	0.00231	CcSEcCtD
Cinacalcet—Body temperature increased—Erlotinib—pancreatic cancer	0.000378	0.00231	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000377	0.0023	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000377	0.00466	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CNR2—pancreatic cancer	0.000377	0.00466	CbGpPWpGaD
Cinacalcet—Anaemia—Gemcitabine—pancreatic cancer	0.000376	0.0023	CcSEcCtD
Cinacalcet—Paraesthesia—Sunitinib—pancreatic cancer	0.000372	0.00227	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000371	0.00458	CbGpPWpGaD
Cinacalcet—Anaemia—Fluorouracil—pancreatic cancer	0.00037	0.00226	CcSEcCtD
Cinacalcet—Dyspnoea—Sunitinib—pancreatic cancer	0.000369	0.00226	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—SCT—pancreatic cancer	0.000368	0.00455	CbGpPWpGaD
Cinacalcet—Cough—Irinotecan—pancreatic cancer	0.000365	0.00223	CcSEcCtD
Cinacalcet—Dyspepsia—Sunitinib—pancreatic cancer	0.000365	0.00223	CcSEcCtD
Cinacalcet—Hypertension—Irinotecan—pancreatic cancer	0.000361	0.0022	CcSEcCtD
Cinacalcet—Decreased appetite—Sunitinib—pancreatic cancer	0.00036	0.0022	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000358	0.00218	CcSEcCtD
Cinacalcet—Fatigue—Sunitinib—pancreatic cancer	0.000357	0.00218	CcSEcCtD
Cinacalcet—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000356	0.00218	CcSEcCtD
Cinacalcet—Cough—Gemcitabine—pancreatic cancer	0.000355	0.00217	CcSEcCtD
Cinacalcet—Constipation—Sunitinib—pancreatic cancer	0.000354	0.00216	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PRLHR—pancreatic cancer	0.000352	0.00435	CbGpPWpGaD
Cinacalcet—Hypertension—Gemcitabine—pancreatic cancer	0.000352	0.00215	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCK—pancreatic cancer	0.000351	0.00434	CbGpPWpGaD
Cinacalcet—Asthenia—Tamoxifen—pancreatic cancer	0.000347	0.00212	CcSEcCtD
Cinacalcet—Convulsion—Fluorouracil—pancreatic cancer	0.000347	0.00212	CcSEcCtD
Cinacalcet—Chest pain—Gemcitabine—pancreatic cancer	0.000347	0.00212	CcSEcCtD
Cinacalcet—Myalgia—Gemcitabine—pancreatic cancer	0.000347	0.00212	CcSEcCtD
Cinacalcet—Arthralgia—Gemcitabine—pancreatic cancer	0.000347	0.00212	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000344	0.0021	CcSEcCtD
Cinacalcet—Asthenia—Erlotinib—pancreatic cancer	0.000343	0.0021	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—GLP1R—pancreatic cancer	0.000342	0.00423	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CNR2—pancreatic cancer	0.000342	0.00423	CbGpPWpGaD
Cinacalcet—Pruritus—Tamoxifen—pancreatic cancer	0.000342	0.00209	CcSEcCtD
Cinacalcet—Myalgia—Fluorouracil—pancreatic cancer	0.000341	0.00208	CcSEcCtD
Cinacalcet—Chest pain—Fluorouracil—pancreatic cancer	0.000341	0.00208	CcSEcCtD
Cinacalcet—Infection—Irinotecan—pancreatic cancer	0.000339	0.00207	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000339	0.00207	CcSEcCtD
Cinacalcet—Pruritus—Erlotinib—pancreatic cancer	0.000338	0.00207	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCKAR—pancreatic cancer	0.000337	0.00416	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Irinotecan—pancreatic cancer	0.000335	0.00204	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—IAPP—pancreatic cancer	0.000334	0.00412	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000334	0.00412	CbGpPWpGaD
Cinacalcet—Cardiac failure—Epirubicin—pancreatic cancer	0.000332	0.00203	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—ZNRF3—pancreatic cancer	0.000331	0.00409	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ACVR1B—pancreatic cancer	0.000331	0.00409	CbGpPWpGaD
Cinacalcet—Diarrhoea—Tamoxifen—pancreatic cancer	0.000331	0.00202	CcSEcCtD
Cinacalcet—Infection—Gemcitabine—pancreatic cancer	0.00033	0.00202	CcSEcCtD
Cinacalcet—Body temperature increased—Sunitinib—pancreatic cancer	0.000327	0.002	CcSEcCtD
Cinacalcet—Abdominal pain—Sunitinib—pancreatic cancer	0.000327	0.002	CcSEcCtD
Cinacalcet—Diarrhoea—Erlotinib—pancreatic cancer	0.000327	0.002	CcSEcCtD
Cinacalcet—Oedema peripheral—Docetaxel—pancreatic cancer	0.000327	0.002	CcSEcCtD
Cinacalcet—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000326	0.00199	CcSEcCtD
Cinacalcet—Anorexia—Irinotecan—pancreatic cancer	0.000325	0.00199	CcSEcCtD
Cinacalcet—Infection—Fluorouracil—pancreatic cancer	0.000325	0.00198	CcSEcCtD
Cinacalcet—Pain in extremity—Epirubicin—pancreatic cancer	0.000324	0.00198	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000324	0.00198	CcSEcCtD
Cinacalcet—Skin disorder—Gemcitabine—pancreatic cancer	0.000323	0.00197	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00032	0.00396	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00032	0.00196	CcSEcCtD
Cinacalcet—Dizziness—Tamoxifen—pancreatic cancer	0.00032	0.00195	CcSEcCtD
Cinacalcet—Hypotension—Irinotecan—pancreatic cancer	0.000319	0.00195	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.000318	0.00393	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.000318	0.00393	CbGpPWpGaD
Cinacalcet—Anorexia—Gemcitabine—pancreatic cancer	0.000317	0.00193	CcSEcCtD
Cinacalcet—Dizziness—Erlotinib—pancreatic cancer	0.000316	0.00193	CcSEcCtD
Cinacalcet—Anorexia—Fluorouracil—pancreatic cancer	0.000311	0.0019	CcSEcCtD
Cinacalcet—Hypotension—Gemcitabine—pancreatic cancer	0.000311	0.0019	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.00031	0.00383	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.00031	0.00383	CbGpPWpGaD
Cinacalcet—Vomiting—Tamoxifen—pancreatic cancer	0.000307	0.00188	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—SHH—pancreatic cancer	0.000307	0.00379	CbGpPWpGaD
Cinacalcet—Cardiac failure—Doxorubicin—pancreatic cancer	0.000307	0.00187	CcSEcCtD
Cinacalcet—Paraesthesia—Irinotecan—pancreatic cancer	0.000306	0.00187	CcSEcCtD
Cinacalcet—Hypotension—Fluorouracil—pancreatic cancer	0.000305	0.00186	CcSEcCtD
Cinacalcet—Hypersensitivity—Sunitinib—pancreatic cancer	0.000305	0.00186	CcSEcCtD
Cinacalcet—Rash—Tamoxifen—pancreatic cancer	0.000305	0.00186	CcSEcCtD
Cinacalcet—Dermatitis—Tamoxifen—pancreatic cancer	0.000305	0.00186	CcSEcCtD
Cinacalcet—Vomiting—Erlotinib—pancreatic cancer	0.000304	0.00186	CcSEcCtD
Cinacalcet—Dyspnoea—Irinotecan—pancreatic cancer	0.000304	0.00186	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—IAPP—pancreatic cancer	0.000303	0.00375	CbGpPWpGaD
Cinacalcet—Headache—Tamoxifen—pancreatic cancer	0.000303	0.00185	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000303	0.00185	CcSEcCtD
Cinacalcet—Rash—Erlotinib—pancreatic cancer	0.000302	0.00184	CcSEcCtD
Cinacalcet—Dermatitis—Erlotinib—pancreatic cancer	0.000301	0.00184	CcSEcCtD
Cinacalcet—Dehydration—Epirubicin—pancreatic cancer	0.000301	0.00184	CcSEcCtD
Cinacalcet—Dyspepsia—Irinotecan—pancreatic cancer	0.0003	0.00183	CcSEcCtD
Cinacalcet—Immune system disorder—Docetaxel—pancreatic cancer	0.0003	0.00183	CcSEcCtD
Cinacalcet—Headache—Erlotinib—pancreatic cancer	0.0003	0.00183	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000299	0.00183	CcSEcCtD
Cinacalcet—Pain in extremity—Doxorubicin—pancreatic cancer	0.000299	0.00183	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SSTR3—pancreatic cancer	0.000299	0.0037	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DTX1—pancreatic cancer	0.000299	0.0037	CbGpPWpGaD
Cinacalcet—Paraesthesia—Gemcitabine—pancreatic cancer	0.000298	0.00182	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000298	0.00182	CcSEcCtD
Cinacalcet—Asthenia—Sunitinib—pancreatic cancer	0.000297	0.00181	CcSEcCtD
Cinacalcet—Decreased appetite—Irinotecan—pancreatic cancer	0.000297	0.00181	CcSEcCtD
Cinacalcet—Arrhythmia—Docetaxel—pancreatic cancer	0.000297	0.00181	CcSEcCtD
Cinacalcet—Dyspnoea—Gemcitabine—pancreatic cancer	0.000296	0.00181	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000295	0.0018	CcSEcCtD
Cinacalcet—Fatigue—Irinotecan—pancreatic cancer	0.000294	0.0018	CcSEcCtD
Cinacalcet—Paraesthesia—Fluorouracil—pancreatic cancer	0.000293	0.00179	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—SST—pancreatic cancer	0.000293	0.00362	CbGpPWpGaD
Cinacalcet—Pruritus—Sunitinib—pancreatic cancer	0.000293	0.00179	CcSEcCtD
Cinacalcet—Constipation—Irinotecan—pancreatic cancer	0.000292	0.00178	CcSEcCtD
Cinacalcet—Dyspnoea—Fluorouracil—pancreatic cancer	0.000291	0.00178	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTHLH—pancreatic cancer	0.000291	0.0036	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PTCH1—pancreatic cancer	0.000291	0.0036	CbGpPWpGaD
Cinacalcet—Malnutrition—Docetaxel—pancreatic cancer	0.000289	0.00176	CcSEcCtD
Cinacalcet—Decreased appetite—Gemcitabine—pancreatic cancer	0.000289	0.00176	CcSEcCtD
Cinacalcet—Dyspepsia—Fluorouracil—pancreatic cancer	0.000288	0.00176	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000287	0.00355	CbGpPWpGaD
Cinacalcet—Nausea—Tamoxifen—pancreatic cancer	0.000287	0.00175	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SSTR1—pancreatic cancer	0.000287	0.00355	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000287	0.00175	CcSEcCtD
Cinacalcet—Fatigue—Gemcitabine—pancreatic cancer	0.000287	0.00175	CcSEcCtD
Cinacalcet—Constipation—Gemcitabine—pancreatic cancer	0.000284	0.00174	CcSEcCtD
Cinacalcet—Nausea—Erlotinib—pancreatic cancer	0.000284	0.00174	CcSEcCtD
Cinacalcet—Decreased appetite—Fluorouracil—pancreatic cancer	0.000284	0.00173	CcSEcCtD
Cinacalcet—Diarrhoea—Sunitinib—pancreatic cancer	0.000283	0.00173	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000282	0.00172	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PPY—pancreatic cancer	0.000281	0.00348	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000279	0.0017	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—pancreatic cancer	0.000278	0.0017	CcSEcCtD
Cinacalcet—Muscle spasms—Docetaxel—pancreatic cancer	0.000278	0.0017	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SSTR2—pancreatic cancer	0.000276	0.00341	CbGpPWpGaD
Cinacalcet—Dizziness—Sunitinib—pancreatic cancer	0.000274	0.00167	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CNR1—pancreatic cancer	0.00027	0.00334	CbGpPWpGaD
Cinacalcet—Abdominal pain—Irinotecan—pancreatic cancer	0.00027	0.00165	CcSEcCtD
Cinacalcet—Body temperature increased—Irinotecan—pancreatic cancer	0.00027	0.00165	CcSEcCtD
Cinacalcet—Anaemia—Docetaxel—pancreatic cancer	0.000267	0.00163	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCKBR—pancreatic cancer	0.000267	0.0033	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—SST—pancreatic cancer	0.000266	0.00329	CbGpPWpGaD
Cinacalcet—Vomiting—Sunitinib—pancreatic cancer	0.000263	0.00161	CcSEcCtD
Cinacalcet—Body temperature increased—Gemcitabine—pancreatic cancer	0.000263	0.0016	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000262	0.00324	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—GCG—pancreatic cancer	0.000261	0.00323	CbGpPWpGaD
Cinacalcet—Rash—Sunitinib—pancreatic cancer	0.000261	0.00159	CcSEcCtD
Cinacalcet—Dermatitis—Sunitinib—pancreatic cancer	0.000261	0.00159	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.00026	0.00159	CcSEcCtD
Cinacalcet—Urticaria—Fluorouracil—pancreatic cancer	0.00026	0.00159	CcSEcCtD
Cinacalcet—Headache—Sunitinib—pancreatic cancer	0.000259	0.00158	CcSEcCtD
Cinacalcet—Body temperature increased—Fluorouracil—pancreatic cancer	0.000258	0.00158	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000254	0.00314	CbGpPWpGaD
Cinacalcet—Cough—Docetaxel—pancreatic cancer	0.000252	0.00154	CcSEcCtD
Cinacalcet—Hypersensitivity—Irinotecan—pancreatic cancer	0.000251	0.00154	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GLI1—pancreatic cancer	0.000251	0.0031	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DTX4—pancreatic cancer	0.000251	0.0031	CbGpPWpGaD
Cinacalcet—Convulsion—Docetaxel—pancreatic cancer	0.00025	0.00153	CcSEcCtD
Cinacalcet—Hypertension—Docetaxel—pancreatic cancer	0.000249	0.00152	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000249	0.00308	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000247	0.00306	CbGpPWpGaD
Cinacalcet—Myalgia—Docetaxel—pancreatic cancer	0.000246	0.0015	CcSEcCtD
Cinacalcet—Chest pain—Docetaxel—pancreatic cancer	0.000246	0.0015	CcSEcCtD
Cinacalcet—Arthralgia—Docetaxel—pancreatic cancer	0.000246	0.0015	CcSEcCtD
Cinacalcet—Nausea—Sunitinib—pancreatic cancer	0.000246	0.0015	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CNR1—pancreatic cancer	0.000246	0.00303	CbGpPWpGaD
Cinacalcet—Asthenia—Irinotecan—pancreatic cancer	0.000245	0.0015	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000244	0.00149	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NRP1—pancreatic cancer	0.000244	0.00301	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000244	0.00301	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000241	0.00298	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000241	0.00147	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000241	0.00147	CcSEcCtD
Cinacalcet—Asthenia—Gemcitabine—pancreatic cancer	0.000238	0.00146	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—GCG—pancreatic cancer	0.000237	0.00293	CbGpPWpGaD
Cinacalcet—Pruritus—Gemcitabine—pancreatic cancer	0.000235	0.00144	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HEY2—pancreatic cancer	0.000235	0.0029	CbGpPWpGaD
Cinacalcet—Infection—Docetaxel—pancreatic cancer	0.000234	0.00143	CcSEcCtD
Cinacalcet—Diarrhoea—Irinotecan—pancreatic cancer	0.000233	0.00143	CcSEcCtD
Cinacalcet—Nervous system disorder—Docetaxel—pancreatic cancer	0.000231	0.00141	CcSEcCtD
Cinacalcet—Pruritus—Fluorouracil—pancreatic cancer	0.000231	0.00141	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GAST—pancreatic cancer	0.000229	0.00283	CbGpPWpGaD
Cinacalcet—Skin disorder—Docetaxel—pancreatic cancer	0.000229	0.0014	CcSEcCtD
Cinacalcet—Diarrhoea—Gemcitabine—pancreatic cancer	0.000227	0.00139	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000227	0.00281	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000226	0.0028	CbGpPWpGaD
Cinacalcet—Dizziness—Irinotecan—pancreatic cancer	0.000226	0.00138	CcSEcCtD
Cinacalcet—Anorexia—Docetaxel—pancreatic cancer	0.000225	0.00137	CcSEcCtD
Cinacalcet—Diarrhoea—Fluorouracil—pancreatic cancer	0.000224	0.00137	CcSEcCtD
Cinacalcet—Oedema peripheral—Epirubicin—pancreatic cancer	0.000221	0.00135	CcSEcCtD
Cinacalcet—Hypotension—Docetaxel—pancreatic cancer	0.00022	0.00135	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SCT—pancreatic cancer	0.000217	0.00269	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HEY1—pancreatic cancer	0.000217	0.00269	CbGpPWpGaD
Cinacalcet—Vomiting—Irinotecan—pancreatic cancer	0.000217	0.00132	CcSEcCtD
Cinacalcet—Dizziness—Fluorouracil—pancreatic cancer	0.000216	0.00132	CcSEcCtD
Cinacalcet—Rash—Irinotecan—pancreatic cancer	0.000215	0.00131	CcSEcCtD
Cinacalcet—Dermatitis—Irinotecan—pancreatic cancer	0.000215	0.00131	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000215	0.00131	CcSEcCtD
Cinacalcet—Headache—Irinotecan—pancreatic cancer	0.000214	0.00131	CcSEcCtD
Cinacalcet—Paraesthesia—Docetaxel—pancreatic cancer	0.000212	0.00129	CcSEcCtD
Cinacalcet—Vomiting—Gemcitabine—pancreatic cancer	0.000211	0.00129	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.00021	0.0026	CbGpPWpGaD
Cinacalcet—Dyspnoea—Docetaxel—pancreatic cancer	0.00021	0.00128	CcSEcCtD
Cinacalcet—Rash—Gemcitabine—pancreatic cancer	0.00021	0.00128	CcSEcCtD
Cinacalcet—Dermatitis—Gemcitabine—pancreatic cancer	0.000209	0.00128	CcSEcCtD
Cinacalcet—Headache—Gemcitabine—pancreatic cancer	0.000208	0.00127	CcSEcCtD
Cinacalcet—Vomiting—Fluorouracil—pancreatic cancer	0.000208	0.00127	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000208	0.00256	CbGpPWpGaD
Cinacalcet—Dyspepsia—Docetaxel—pancreatic cancer	0.000208	0.00127	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCK—pancreatic cancer	0.000207	0.00256	CbGpPWpGaD
Cinacalcet—Rash—Fluorouracil—pancreatic cancer	0.000206	0.00126	CcSEcCtD
Cinacalcet—Dermatitis—Fluorouracil—pancreatic cancer	0.000206	0.00126	CcSEcCtD
Cinacalcet—Decreased appetite—Docetaxel—pancreatic cancer	0.000205	0.00125	CcSEcCtD
Cinacalcet—Headache—Fluorouracil—pancreatic cancer	0.000205	0.00125	CcSEcCtD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000204	0.00253	CbGpPWpGaD
Cinacalcet—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000204	0.00125	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000204	0.00124	CcSEcCtD
Cinacalcet—Fatigue—Docetaxel—pancreatic cancer	0.000203	0.00124	CcSEcCtD
Cinacalcet—Nausea—Irinotecan—pancreatic cancer	0.000203	0.00124	CcSEcCtD
Cinacalcet—Immune system disorder—Epirubicin—pancreatic cancer	0.000202	0.00124	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CNR2—pancreatic cancer	0.000202	0.0025	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GLP1R—pancreatic cancer	0.000202	0.0025	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000202	0.0025	CbGpPWpGaD
Cinacalcet—Constipation—Docetaxel—pancreatic cancer	0.000202	0.00123	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—pancreatic cancer	0.0002	0.00122	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCKAR—pancreatic cancer	0.000199	0.00246	CbGpPWpGaD
Cinacalcet—Nausea—Gemcitabine—pancreatic cancer	0.000197	0.00121	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—pancreatic cancer	0.000195	0.00119	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—pancreatic cancer	0.000194	1	CrCbGaD
Cinacalcet—Nausea—Fluorouracil—pancreatic cancer	0.000194	0.00119	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—JAG2—pancreatic cancer	0.000193	0.00238	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000193	0.00118	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—MEN1—pancreatic cancer	0.00019	0.00235	CbGpPWpGaD
Cinacalcet—Muscle spasms—Epirubicin—pancreatic cancer	0.000187	0.00114	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—pancreatic cancer	0.000187	0.00114	CcSEcCtD
Cinacalcet—Body temperature increased—Docetaxel—pancreatic cancer	0.000186	0.00114	CcSEcCtD
Cinacalcet—Abdominal pain—Docetaxel—pancreatic cancer	0.000186	0.00114	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—pancreatic cancer	0.000185	0.00113	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SHH—pancreatic cancer	0.000181	0.00224	CbGpPWpGaD
Cinacalcet—Malnutrition—Doxorubicin—pancreatic cancer	0.00018	0.0011	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NOTCH4—pancreatic cancer	0.00018	0.00223	CbGpPWpGaD
Cinacalcet—Anaemia—Epirubicin—pancreatic cancer	0.00018	0.0011	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—IAPP—pancreatic cancer	0.000179	0.00221	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Docetaxel—pancreatic cancer	0.000174	0.00106	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—pancreatic cancer	0.000173	0.00106	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000173	0.00213	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTHLH—pancreatic cancer	0.000172	0.00212	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTCH1—pancreatic cancer	0.000172	0.00212	CbGpPWpGaD
Cinacalcet—Cough—Epirubicin—pancreatic cancer	0.00017	0.00104	CcSEcCtD
Cinacalcet—Asthenia—Docetaxel—pancreatic cancer	0.000169	0.00103	CcSEcCtD
Cinacalcet—Convulsion—Epirubicin—pancreatic cancer	0.000169	0.00103	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—pancreatic cancer	0.000168	0.00103	CcSEcCtD
Cinacalcet—Pruritus—Docetaxel—pancreatic cancer	0.000167	0.00102	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—pancreatic cancer	0.000167	0.00102	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000165	0.00101	CcSEcCtD
Cinacalcet—Diarrhoea—Docetaxel—pancreatic cancer	0.000161	0.000986	CcSEcCtD
Cinacalcet—Infection—Epirubicin—pancreatic cancer	0.000158	0.000965	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—pancreatic cancer	0.000157	0.000961	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SST—pancreatic cancer	0.000157	0.00194	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000157	0.00194	CbGpPWpGaD
Cinacalcet—Convulsion—Doxorubicin—pancreatic cancer	0.000156	0.000954	CcSEcCtD
Cinacalcet—Nervous system disorder—Epirubicin—pancreatic cancer	0.000156	0.000953	CcSEcCtD
Cinacalcet—Dizziness—Docetaxel—pancreatic cancer	0.000156	0.000953	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—pancreatic cancer	0.000156	0.000951	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000155	0.00192	CbGpPWpGaD
Cinacalcet—Skin disorder—Epirubicin—pancreatic cancer	0.000155	0.000944	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—JAG1—pancreatic cancer	0.000154	0.0019	CbGpPWpGaD
Cinacalcet—Myalgia—Doxorubicin—pancreatic cancer	0.000154	0.000938	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—pancreatic cancer	0.000154	0.000938	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—pancreatic cancer	0.000154	0.000938	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000153	0.00189	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000152	0.000931	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—pancreatic cancer	0.000152	0.000926	CcSEcCtD
Cinacalcet—Vomiting—Docetaxel—pancreatic cancer	0.00015	0.000916	CcSEcCtD
Cinacalcet—Rash—Docetaxel—pancreatic cancer	0.000149	0.000908	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—pancreatic cancer	0.000149	0.000908	CcSEcCtD
Cinacalcet—Dermatitis—Docetaxel—pancreatic cancer	0.000149	0.000907	CcSEcCtD
Cinacalcet—Headache—Docetaxel—pancreatic cancer	0.000148	0.000902	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—pancreatic cancer	0.000146	0.000893	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CNR1—pancreatic cancer	0.000145	0.00179	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000145	0.000885	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000144	0.000882	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—pancreatic cancer	0.000143	0.000873	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—pancreatic cancer	0.000143	0.000872	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—pancreatic cancer	0.000142	0.000866	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000141	0.00174	CbGpPWpGaD
Cinacalcet—Anorexia—Doxorubicin—pancreatic cancer	0.00014	0.000857	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GCG—pancreatic cancer	0.00014	0.00173	CbGpPWpGaD
Cinacalcet—Nausea—Docetaxel—pancreatic cancer	0.00014	0.000856	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—pancreatic cancer	0.00014	0.000855	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—pancreatic cancer	0.000138	0.000845	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—pancreatic cancer	0.000138	0.00084	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000137	0.000839	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—pancreatic cancer	0.000137	0.000838	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000136	0.00168	CbGpPWpGaD
Cinacalcet—Constipation—Epirubicin—pancreatic cancer	0.000136	0.000831	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000134	0.000819	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—AGTR1—pancreatic cancer	0.000134	0.00165	CbGpPWpGaD
Cinacalcet—Paraesthesia—Doxorubicin—pancreatic cancer	0.000132	0.000807	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—STK11—pancreatic cancer	0.000132	0.00163	CbGpPWpGaD
Cinacalcet—Dyspnoea—Doxorubicin—pancreatic cancer	0.000131	0.000801	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00013	0.000794	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—pancreatic cancer	0.00013	0.000791	CcSEcCtD
Cinacalcet—Decreased appetite—Doxorubicin—pancreatic cancer	0.000128	0.000781	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000127	0.000776	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—pancreatic cancer	0.000127	0.000775	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—pancreatic cancer	0.000126	0.000772	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—pancreatic cancer	0.000126	0.000769	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—pancreatic cancer	0.000126	0.000768	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—pancreatic cancer	0.000126	0.000768	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000124	0.00153	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000121	0.00149	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00012	0.000735	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000119	0.00147	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000118	0.00146	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Epirubicin—pancreatic cancer	0.000117	0.000716	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—pancreatic cancer	0.000117	0.000714	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—pancreatic cancer	0.000116	0.000711	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—pancreatic cancer	0.000116	0.000711	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SMAD4—pancreatic cancer	0.000115	0.00143	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000114	0.00141	CbGpPWpGaD
Cinacalcet—Asthenia—Epirubicin—pancreatic cancer	0.000114	0.000697	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HES1—pancreatic cancer	0.000113	0.00139	CbGpPWpGaD
Cinacalcet—Pruritus—Epirubicin—pancreatic cancer	0.000113	0.000687	CcSEcCtD
Cinacalcet—Diarrhoea—Epirubicin—pancreatic cancer	0.000109	0.000665	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000108	0.000662	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000108	0.00133	CbGpPWpGaD
Cinacalcet—Asthenia—Doxorubicin—pancreatic cancer	0.000106	0.000645	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—pancreatic cancer	0.000105	0.000642	CcSEcCtD
Cinacalcet—Pruritus—Doxorubicin—pancreatic cancer	0.000104	0.000636	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—pancreatic cancer	0.000104	0.00128	CbGpPWpGaD
Cinacalcet—Vomiting—Epirubicin—pancreatic cancer	0.000101	0.000618	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—pancreatic cancer	0.000101	0.000615	CcSEcCtD
Cinacalcet—Rash—Epirubicin—pancreatic cancer	0.0001	0.000613	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—pancreatic cancer	0.0001	0.000612	CcSEcCtD
Cinacalcet—Headache—Epirubicin—pancreatic cancer	9.97e-05	0.000609	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—TERT—pancreatic cancer	9.87e-05	0.00122	CbGpPWpGaD
Cinacalcet—Dizziness—Doxorubicin—pancreatic cancer	9.73e-05	0.000594	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	9.69e-05	0.0012	CbGpPWpGaD
Cinacalcet—Nausea—Epirubicin—pancreatic cancer	9.45e-05	0.000577	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HIF1A—pancreatic cancer	9.44e-05	0.00117	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TSC2—pancreatic cancer	9.42e-05	0.00116	CbGpPWpGaD
Cinacalcet—Vomiting—Doxorubicin—pancreatic cancer	9.36e-05	0.000572	CcSEcCtD
Cinacalcet—Rash—Doxorubicin—pancreatic cancer	9.28e-05	0.000567	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—pancreatic cancer	9.27e-05	0.000566	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—pancreatic cancer	9.22e-05	0.000563	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—APOE—pancreatic cancer	9.22e-05	0.00114	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.06e-05	0.00112	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KDR—pancreatic cancer	9.03e-05	0.00112	CbGpPWpGaD
Cinacalcet—Nausea—Doxorubicin—pancreatic cancer	8.74e-05	0.000534	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—NFKBIA—pancreatic cancer	8.59e-05	0.00106	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOTCH1—pancreatic cancer	8.51e-05	0.00105	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CG—pancreatic cancer	8.32e-05	0.00103	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—NRAS—pancreatic cancer	8.32e-05	0.00103	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGF—pancreatic cancer	8.22e-05	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	7.83e-05	0.000968	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	7.83e-05	0.000968	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	7.63e-05	0.000942	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—pancreatic cancer	7.58e-05	0.000936	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	7.54e-05	0.000931	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CD—pancreatic cancer	7.31e-05	0.000903	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.24e-05	0.000895	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—pancreatic cancer	7.16e-05	0.000885	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	7.02e-05	0.000867	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	7e-05	0.000865	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	6.87e-05	0.000848	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	6.87e-05	0.000848	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—pancreatic cancer	6.58e-05	0.000813	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	6.54e-05	0.000808	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	6.54e-05	0.000808	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	6.49e-05	0.000801	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CB—pancreatic cancer	6.37e-05	0.000788	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—pancreatic cancer	6.13e-05	0.000757	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—HRAS—pancreatic cancer	6.09e-05	0.000752	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—pancreatic cancer	5.92e-05	0.000731	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP3—pancreatic cancer	5.86e-05	0.000724	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—pancreatic cancer	5.71e-05	0.000705	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—pancreatic cancer	5.65e-05	0.000698	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—pancreatic cancer	5.54e-05	0.000684	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	5.51e-05	0.000681	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—pancreatic cancer	5.51e-05	0.00068	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—pancreatic cancer	5.37e-05	0.000664	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SRC—pancreatic cancer	5.11e-05	0.000631	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—pancreatic cancer	4.98e-05	0.000615	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—pancreatic cancer	4.93e-05	0.000609	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NRAS—pancreatic cancer	4.91e-05	0.000607	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—pancreatic cancer	4.58e-05	0.000566	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—pancreatic cancer	4.57e-05	0.000564	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—pancreatic cancer	4.48e-05	0.000553	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—pancreatic cancer	4.23e-05	0.000523	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—pancreatic cancer	3.89e-05	0.00048	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—pancreatic cancer	3.76e-05	0.000464	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—pancreatic cancer	3.6e-05	0.000444	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.57e-05	0.000441	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—pancreatic cancer	3.17e-05	0.000392	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.09e-05	0.000382	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PRSS1—pancreatic cancer	3.02e-05	0.000373	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.7e-05	0.000334	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ARG2—pancreatic cancer	2.62e-05	0.000324	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.33e-05	0.000288	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.29e-05	0.000283	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.18e-05	0.000269	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.14e-05	0.000265	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.03e-05	0.000251	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.02e-05	0.00025	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.89e-05	0.000233	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.85e-05	0.000228	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.82e-05	0.000224	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.77e-05	0.000218	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.72e-05	0.000213	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.71e-05	0.000211	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.65e-05	0.000203	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000195	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GCG—pancreatic cancer	1.51e-05	0.000187	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.5e-05	0.000185	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.42e-05	0.000176	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—STK11—pancreatic cancer	1.42e-05	0.000175	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.4e-05	0.000173	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CD44—pancreatic cancer	1.33e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.33e-05	0.000164	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.31e-05	0.000161	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.29e-05	0.00016	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.22e-05	0.000151	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—STK11—pancreatic cancer	1.2e-05	0.000149	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.13e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.03e-05	0.000128	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CD44—pancreatic cancer	1.03e-05	0.000127	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APOE—pancreatic cancer	9.93e-06	0.000123	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GCG—pancreatic cancer	9.87e-06	0.000122	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—STK11—pancreatic cancer	9.28e-06	0.000115	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.97e-06	0.000111	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.65e-06	0.000107	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APOE—pancreatic cancer	8.42e-06	0.000104	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.99e-06	9.87e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.97e-06	9.84e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.88e-06	9.74e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	7.6e-06	9.38e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—pancreatic cancer	7.33e-06	9.06e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.87e-06	8.49e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.81e-06	8.41e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	6.68e-06	8.25e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APOE—pancreatic cancer	6.5e-06	8.02e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.94e-06	7.33e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.86e-06	7.24e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	5.82e-06	7.19e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—pancreatic cancer	5.77e-06	7.12e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.66e-06	6.99e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.15e-06	6.37e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—pancreatic cancer	5.03e-06	6.21e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.49e-06	5.55e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.45e-06	5.5e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.19e-06	5.17e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.88e-06	4.79e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.55e-06	4.38e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.42e-06	4.23e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.9e-06	3.58e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.74e-06	3.38e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.24e-06	2.76e-05	CbGpPWpGaD
